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Healthcare utilization and out-of-pocket
expenditures associated with depression in
adults: a cross-sectional analysis in Nepal
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Abstract
Background: Despite attempts to improve universal health coverage (UHC) in low income countries like Nepal, most
healthcare utilization is still financed by out-of-pocket (OOP) payments, with detrimental effects on the poorest and
most in need. Evidence from high income countries shows that depression is associated with increased healthcare
utilization, which may lead to increased OOP expenditures, placing greater stress on families. To inform policies for
integrating mental healthcare into UHC in LMIC, we must understand healthcare utilization and OOP expenditure
patterns in people with depression. We examined associations between symptoms of depression and frequency and
type of healthcare utilization and OOP expenditure among adults in Chitwan District, Nepal.
Methods: We analysed data from a population-based survey of 2040 adults in 2013, who completed the PHQ-9
screening tool for depression and answered questions about healthcare utilization. We examined associations between
increasing PHQ-9 score and healthcare utilization frequency and OOP expenditure using negative binomial regression.
We also compared utilization of specific outpatient service providers and their related costs among adults with and
without probable depression, determined by a PHQ-9 score of 10 or more.
Results: We classified 80 (3.6%) participants with probable depression, 70.9% of whom used some form of healthcare
in the past year compared to 43.9% of people without probable depression. Mean annual OOP healthcare
expenditures were $118 USD in people with probable depression, compared to $110 USD in people without. With
each unit increase in PHQ-9 score, there was a 14% increase in total healthcare visits (95% CI 7–22%, p < 0.0001) and $9
USD increase in OOP expenditures (95% CI $2–$17; p < 0.0001). People with depression sought most healthcare from
pharmacists (30.1%) but reported the greatest expenditure on specialist doctors ($36 USD).
Conclusions: In this population-based sample from Central Nepal, we identified dose-dependent increases in
healthcare utilization and OOP expenditure with increasing PHQ-9 scores. Future studies should evaluate whether
provision of mental health services as an integrated component of UHC can improve overall health and reduce
healthcare utilisation and expenditure, thereby alleviating financial pressures on families.
Keywords: Major depressive disorder, Nepal, Health services, Hospitalization, Out-of-pocket expenditures
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: luitelnp@gmail.com
3Research Department, Transcultural Psychosocial Organization Nepal,
Kathmandu, Nepal
Full list of author information is available at the end of the article
Rajan et al. BMC Health Services Research          (2020) 20:250 
https://doi.org/10.1186/s12913-020-05094-9
Background
In an international pursuit to reduce global poverty and
improve population health, the world’s governments have
committed, in the Sustainable Development Goals, to
achieve universal health coverage (UHC), including finan-
cial risk protection by 2030 [1]. A critical decision in the
progressive realisation of UHC is which health services to
include in essential packages of care. There is evidence
that mental health interventions can be cost-effective [2,
3], and several prominent mental health advocates have
recommended their inclusion in UHC [4–7]. Besides be-
ing a major contributor to the burden of disability world-
wide [8], much of which falls on low- and middle-income
countries (LMIC) [9], there are also strong economic ar-
guments for the inclusion of basic mental health care in
UHC. The global economic burden of mental disorders
comes to $2.5 trillion USD per year, projected to double
by 2030, of which two thirds arises from lost earnings and
one third directly from healthcare expenditure [2].
To inform national policies for achieving UHC, and
decisions around which interventions to prioritise in low-
resource settings, we need to understand patterns of
healthcare utilization and out-of-pocket payments (OOP).
There is evidence from North America and Europe that
healthcare expenditure is more than twice as high in
people with depression than those without [10–14] sug-
gesting that this group places a disproportionate burden
on health systems, whose needs are important to consider
when planning UHC. However, it is unknown whether
this finding is generalisable to other countries with vastly
different health systems. In LMIC, where healthcare is
predominantly financed by OOP payments [15], any in-
creased utilization can lead to impoverishment, itself a
major risk factor for depression [16], and can result in the
poorest individuals foregoing necessary care [17].
Nepal is a low-income fragile state, where prolonged
conflict, trauma and natural disasters have contributed
to a weakened health system in which 60% of total
healthcare expenditure is privately funded, of which 80%
is OOP [18]. The Nepalese government has made signifi-
cant efforts to improve UHC in the last 5 years, with so-
cial health insurance now available in 42 out of 77 of its
districts [19]. However, uptake remains low, with only
6% of the population signing up to the scheme [19], and
specialist mental health services remain unavailable for
the majority of individuals with mental disorders [20].
At present there is no data from Nepal on healthcare
utilization by people with depression, in order to inform
policies around including depression treatment care in
UHC to address this group’s needs and reduce OOP
spending. While there is some evidence that OOP ex-
penditures increase among older people with depression
in southern India [21], the available evidence from
elsewhere in LMIC shows that community healthcare
utilization by people with depression varies considerably
between countries [22].
Recent evidence from the Programme for Improving
Mental Health CarE (PRIME) [23] demonstrates the
feasibility [24, 25] and effectiveness of integrating mental
health services into primary healthcare settings in Nepal,
based on the WHO Mental Health Gap Action Programme
(mhGAP) [26]. Modelled estimates suggest that this kind of
integration could be scaled-up nationally for an investment
of $5.55 US dollars per capita, spread over 7 years [27]. The
PRIME approach provides a potential model upon which to
base integrated services if mental health care were included
in UHC. Understanding patterns of healthcare utilization
and OOP expenditure by people with depression can help
us to predict the likely financial and health service impacts
of implementing this policy in Nepal.
In this secondary analysis of data from the PRIME study,
we set out to examine associations between increasing
symptoms of depression and healthcare utilization and re-
lated OOP expenditure among adults in one district in
Central Nepal. In our definition of healthcare utilization,
we included hospitalizations and use of any outpatient
healthcare services. These included both generalist and
specialist doctors, mental health specialists, pharmacists
and providers of traditional and complementary medicine.
Our secondary objective was to compare utilization of dif-
ferent outpatient service providers among adults with and
without probable depression and to estimate the mean ex-
penditure associated with each provider type.
Methods
Setting
This study was carried out in Chitwan district in central
Nepal, where some mental health services were already
in existence at the time of study, as described previously
[28, 29]. In previous studies, approximately 41% of
people reported symptoms of depression in the north-
western mountains [30], compared to 3% in this sample
from the central plains [31], of whom only 8.1% accessed
treatment [31]. Despite Chitwan having adopted the Na-
tional Mental Health Policy in 1996, there were only 2
psychiatrists serving its population of over half a million
[32] at the time of the study.
Sampling and participants
The rationale, study design and data collection proce-
dures for the PRIME study have been detailed previously
[31]. Briefly, the PRIME study included a population-
based survey of adults in Chitwan District. Using house-
hold and population data from Village Development
Committees (VDCs; similar to municipalities, with com-
munity participation in their administration) in Chitwan,
the lead investigator randomly selected houses from
each VDC, where field workers enumerated the adults in
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the household and a family member randomly selected 1
adult from a series of concealed papers for recruitment
into the study. Eligibility criteria included age of 18 years
or over, residency in Chitwan, fluency in the Nepali lan-
guage and willingness and ability to provide informed
consent. Between May and August 2013, 99% of eligible
adults provided informed consent and 2040 adults par-
ticipated in the study.
All PRIME participants answered questions about
demographic characteristics and received screening for
probable depression (described below) and alcohol-use
disorder in Part 1 of a two-part survey. To facilitate the
analysis of secondary research questions without over-
burdening research staff and participants, questions
about household economic status, healthcare utilization
and OOP expenditure were only included in Part 2 of
the survey (also described below), which was limited to a
sub-sample of 479 participants. This sub-sample in-
cluded all participants reporting symptoms of depression
(acute or chronic) (213), alcohol-use disorder (78) or
both (18) and a random 10% sample of remaining screen
negative participants (170) as shown in Additional File 1.
The decision to include 10% of remaining participants
was based on an estimated 10% prevalence of alcohol
use disorder or depression, thereby enabling compari-
sons of equal numbers of screen positive and screen
negative participants.
The questionnaire was orally administered by a trained
fieldworker in the Nepali language and responses were
collected on a questionnaire application, which was pro-
grammed onto an Android mobile device.
Measures
Depression status
We screened participants for depression with the 9-item
Patient Health Questionnaire (PHQ-9) [33]. The PHQ-9
grades self-reported symptoms of depression in the previ-
ous 2 weeks and severity is determined by increasing
scores. We interpreted a score of 10 or more to reflect
probable depression, which in a Nepali validation study
had a sensitivity of 0.94 and specificity of 0.80 [34]. In this
sample, the PHQ-9 had a Cronbach’s alpha of 0.79 [31].
Household economic status
Household economic status was evaluated on the basis of
household assets (such as water supply, sanitation facil-
ities, power supply, radios, televisions, mobile phones,
cooking fuel, a separate kitchen and type of flooring) using
an asset score, which was developed specifically for use in
Nepal for the purposes of this study and described further
in Additional File 2. Employing the methods described by
Vyas and Kumaranayake [35], we used principal compo-
nent analysis to generate a relative wealth index from the
asset score, which we subsequently categorized into thirds
to reflect low, average and high wealth categories.
Healthcare utilization
We assessed inpatient and outpatient healthcare
utilization and OOP healthcare expenditure using a ver-
sion of the Client Socio-demographic and Service Re-
ceipt Inventory [36], which has been adapted for use in
LMIC [37]. To measure inpatient healthcare utilization,
we asked participants to report the number of times they
had been admitted to hospital in the previous 12months, if
at all. We then asked participants to report the number of
times, if any, they had visited outpatient services for any
health problem (including but not exclusively for depres-
sion) over the previous 3months including seven types of
healthcare providers: traditional healers, community
workers, nurse/midwives, pharmacists, general doctors, spe-
cialist doctors, and psychiatrists and other mental health
workers. In order to make comparisons between inpatient
and outpatient healthcare utilization and to calculate an es-
timate of total utilization, we standardized the number of
visits in 3months to reflect annual outpatient healthcare
utilization as reported in similar analyses [10, 17, 38]. We
also recorded data on the presenting health complaint.
Healthcare expenditure
For each inpatient hospital admission reported in the
past 12 months, we asked participants to report all indi-
vidual payments for hospital fees, medicines, laboratory
tests and other investigations (including scans), and
transportation incurred both personally and by friends
and family. We used the sum of all these payments to
estimate the annual inpatient OOP expenditure. The in-
clusion of payments for transportation to and from
health facilities in the definition of OOP expenditures is
consistent with other OOP cost studies from LMIC [39].
For each episode of outpatient healthcare utilization
over 3 months, we also asked participants to report all
individual OOP payments for consultations with western
biomedical practitioners or providers of traditional and
complementary medicine as well as return transporta-
tion. We also standardised these payments to reflect an-
nual outpatient OOP expenditure. Finally, we summed
the annual inpatient and outpatient OOP expenditures
to estimate the total annual OOP expenditure. We did
not include opportunity costs or indirect costs such as
lost productivity and all costs were defined from the
user’s perspective. All expenditures were reported in
Nepali Rupees and converted to US dollars according to
the exchange rate at the end of data collection (1 USD:
96.997 Nepali rupee on 02 Aug 2013). We observed one
implausible outlier for outpatient OOP expenditure and
replaced it with the sample’s mean outpatient OOP cost.
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Statistical analysis
First, we report participants’ demographic [40] character-
istics, PHQ-9 scores, frequency of healthcare utilization
and mean OOP expenditures, stratified by depression
screening status. Categorical measures are summarized as
proportions, age as means and standard deviations and
PHQ-9 scores and healthcare utilization (whose distribu-
tion was skewed), as medians and interquartile ranges. We
present mean annual OOP expenditures, overall and by
depression screening status, employing bootstrapping
methods with 1000 replications to estimate standard er-
rors. This method enables estimation of mean expendi-
tures required for health budgeting [41], whilst accounting
for the skewed distribution typical of cost data [42, 43]
and has been used with survey data of this nature previ-
ously [44]. One participant who had missing age was im-
puted to 39.8 years, the mean value for the overall sample.
Second, we assessed the relative changes in annual in-
patient, outpatient and total healthcare utilization (by
number of visits) for each unit increase in PHQ-9 score in
all participants. Given the skew in the distribution of
healthcare utilization, which precluded use of linear re-
gression, we used negative binomial regression. Third, we
estimated the relative changes in inpatient, outpatient and
total OOP healthcare expenditure for each unit increase
in PHQ-9 score using bootstrapped linear regression
models. We adjusted for age, sex and relative wealth index
in all models. We used the relative wealth index as a proxy
for household economic status and specifically for access
to basic necessities, which has been shown in Nepal to
predict healthcare utilization [15]. In exploratory analyses,
we also adjusted for education and occupation as potential
confounders of the association between depression and
healthcare utilization but omitted these from the primary
model to avoid collinearity. We also checked for interac-
tions between PHQ-9 score and relative wealth group. Fi-
nally, we report utilization and mean OOP expenditures
for each outpatient provider type, stratified by probable
depression status.
For each step, survey-adjusted methods were used to ac-
count for the complex sampling design and sampling
probability weights [45]. Data were analysed using Stata
version 14.2 [40]. Ethical approval was obtained from the
Nepal Health Research Council (Kathmandu, Nepal), the
World Health Organization (Geneva, Switzerland) and the
London School of Hygiene and Tropical Medicine.
Results
Demographic characteristics, PHQ-9 scores, healthcare
utilization, and OOP expenditures
Table 1 displays the demographic characteristics, PHQ-9
scores, health care utilization and expenditure of com-
munity survey participants. The mean age of all 2040
participants was 39.8 years (SD 15.2), of whom 59.8%
were female and 54.5% had secondary level education or
higher. The median PHQ-9 score was 2 with a range 0
to 24 and the point prevalence of probable depression
(PHQ-9 ≥ 10) was 3.6%. Probable depression was more
common in participants with the lowest (6.9%) com-
pared to the highest (2.0%) educational attainment), un-
skilled workers (4.2%) compared to business employees
(1.9%) and those among the poorest (6.0%) compared to
the wealthiest (3.1%) third. Of all 479 adults who an-
swered questions about healthcare utilization, 233 had
not used any healthcare, whereas 18 had been admitted
to hospital, 197 had utilised outpatient services and 31
had used both. People with probable depression were
twice as likely to be admitted to hospital (15.8%) as
people without (7.8%) and were also more likely to visit
outpatient services (69.7%) than people without (39.8%).
Participants reported seeking outpatient healthcare for a
wide range of ailments at the first visit. For individuals
with probable depression this was most commonly for
signs and symptoms of infection (20.7%), followed by de-
pression, anxiety or sleep disturbance (14.0%), other
chronic conditions (12.8%), joint pains (9.5%), gastro-
intestinal symptoms (most commonly heartburn) (9.2%),
injuries (8.0%) or routine check-ups (7.9%) with all other
categories under 5%. Among healthcare users without
depression, most used healthcare for joint pains (22.1%),
followed by acute conditions such as allergy (17.1%),
gastrointestinal symptoms (13.9%), infections (9.9%) and
other chronic conditions (8.1%). 88% of participants who
utilised healthcare incurred some OOP expenditure and
the mean total OOP expenditure was $118 USD/year
(SD 265) in adults with probable depression and $110
USD (SD 879) in people without depression.
Healthcare utilization and expenditures and depression
severity
The associations between PHQ-9 score and healthcare
utilization and expenditure are displayed in Table 2. In
univariate analyses, each unit increase in PHQ-9 score
was associated with a 14% increase in outpatient health-
care consultations, a 14% increase in total healthcare
consultations and a weaker 7% increase in inpatient ad-
missions. After adjustment for age, sex and relative
wealth the estimates for outpatient (15% CI 6–23%, P <
0.0001), total (15% CI 7–22%, P < 0.0001), and inpatient
(7% (95% CI -6-22%, P = 0.314) healthcare utilization
were materially unchanged.
For each increment in PHQ-9 score, OOP expenditure
on outpatient and total healthcare increased by $5.52 USD
and $9.15 USD per year respectively. After adjustment for
age, sex and relative wealth, these OOP expenditures were
unchanged for outpatient ($5.36 USD (95% CI 2.36–8.47))
and total ($9.37 USD (95% CI 2.15–16.58) healthcare
utilization (Table 2).
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There was only weak evidence for differences in in-
patient expenditures. None of these reported associa-
tions were modified by relative wealth index during
initial inspection of the data. Exploratory analyses
adjusting additionally for educational attainment and
occupation yielded similar associations between de-
pression and total healthcare utilization (17% (95% CI
9–25%) (including outpatient 17% (95% CI 9–27%);
and inpatient 12% (− 3–29%)) and total OOP health-
care expenditures ($9.84 (1.39–18.30) (including $5.35
(95% CI 2.30–8.40) for outpatient and $4.49 (− 2.55–
11.54) for inpatient). Similarly, the reported associa-
tions between depression and healthcare utilization
were similar after excluding 21 people who used
healthcare for chronic health problems.
Healthcare utilization by provider type
Figure 1 displays the proportion of people with and
without probable depression who used each type of out-
patient healthcare. For each provider, the proportion of
people who reported any outpatient consultations in the
past 3 months was greater among those with probable
depression than those without. Of note, people with de-
pression most commonly sought treatment from phar-
macists (30.1%), who they were 3 times more likely to
visit than people without probable depression. General
Table 1 PHQ-9 scores, sociodemographic and healthcare-
related characteristics of adults in Chitwan District, Nepal, 2013
N Overall (%) PHQ-9
Negative
N = 1960
(96.41%)
PHQ-9
positive
N = 80
(3.56%)
PHQ-9 Scores 2040
Range 0–24 0–9 10–24
Median (IQR) 2 (0–4) 2 (0–4) 11 (10–14)
Demographic
Characteristics
2040
Mean age (SD) 39.77
(15.23)
39.54 (15.06) 45.87
(18.49)
Female 1336 59.75% 96.44% 3.56%
Male 704 40.25% 96.41% 3.59%
Educational Status
Sub primary/illiterate 275 12.83 93.06% 6.94%
Primary/literate 686 32.68 95.17% 4.82%
Secondary or higher 1079 54.49 97.96% 2.04%
Occupation
Agriculture, Labour
or Service
1409 66.40 95.73% 4.23%
Business and Service 302 15.46 98.15% 1.85%
Unemployed 94 4.88 97.01% 2.93%
Student 161 9.99 97.73% 2.27%
Other 74 3.26 97.22% 2.78%
Relative wealth indexa
Low 155 22.27 94.00% 6.00%
Average 162 32.57 96.74% 3.26%
High 161 45.16 96.92% 3.07%
Healthcare Utilizationa 479 399 80
Inpatient 49
Percentage with any
admissions
8.02 7.82 15.83
Median annual number
of visits (IQR)
0 (0–0) 0 (0–0) 0 (0–0)
Outpatient 228
Percentage with any
outpatient visits
39.99 38.83 69.70
Median annual number
of visits (IQR)
0 (0–8) 0 (0–4) 4 (0–8)
Total 246
Percentage with any
healthcare utilization
44.93 43.91 70.85
Median annual number
of visits (IQR)
1 (0–8) 0 (0–5) 4 (0–8)
Healthcare Expenditurea 479
Inpatient 47
Percentage with any
expenditure
99.06 99.19 97.46
Mean annual OOP
expenditure in
USD (SD)
65.94
(766.01)
68.12
(820.59)
53.95
(194.63)
Table 1 PHQ-9 scores, sociodemographic and healthcare-
related characteristics of adults in Chitwan District, Nepal, 2013
(Continued)
N Overall (%) PHQ-9
Negative
N = 1960
(96.41%)
PHQ-9
positive
N = 80
(3.56%)
Outpatient 191
Percentage with any
expenditure
85.58 85.60 88.65
Mean annual OOP
expenditure in
USD (SD)
44.85
(130.81)
41.44
(124.81)
63.71
(161.17)
Total 212
Percentage with any
expenditure
87.86 87.44 97.43
Mean annual OOP
expenditure in USD (SD)
110.80
(822.78)
109.55
(878.97)
117.66
(265.46)
Demographic characteristics are presented as row percentages, while
healthcare utilization and expenditure are presented as
column percentages
Age and OOP healthcare expenditures (US Dollars) are presented as
means and standard deviations (SD), using bootstrapping techniques
with 1000 bootstrap samples to estimate the SD for OOP expenditures
PHQ-9 scores and number of healthcare visits are presented as medians
and interquartile ranges (IQR)
The percentage with any expenditure is calculated as a proportion of
those who utilised inpatient or outpatient care respectively
aRelative wealth index, healthcare utilization and healthcare expenditure
were assessed in 479 of the total 2040 participants who answered part 2
of the survey and all percentages and means are adjusted for
sampling-probability weights
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doctors were the second most common source of treat-
ment seeking in the depressed group (21.2%). In com-
parison, people without depression consulted (non-
mental health) specialist doctors (17.7%) most fre-
quently, whilst few people overall visited traditional
healers (6.7%) or psychiatrists (0.2%).
Provider-specific healthcare expenditure
Participants with probable depression incurred higher an-
nual OOP expenditures for each provider type on average
than participants without, as shown in Fig. 2. In contrast
to utilization patterns, these expenditures were highest for
visits to specialist doctors ($35.99 USD (SD 15.12)),
followed by general doctors ($12.44 USD (SD 6.11)) and
pharmacists ($7.97 USD (SD 3.28)), compared to $3.48
USD (SD 14.21) for traditional healers and $3.03 USD (SD
24.26) for psychiatrists.
Discussion
Principal findings
Our results demonstrate that people with probable depres-
sion in Central Nepal used more healthcare and incurred
greater OOP expenditures than people without depression,
and that both utilization and OOP expenditure increased
significantly with increasing depression screening scores.
People with probable depression incurred total mean ex-
penditures of $118 (SD 29) USD/year OOP on healthcare,
which is likely to represent a substantial proportion of
household budgets considering that median annual income
for adults with depression in this area has been estimated
to be $501 [17]. The association between higher PHQ-9
score and total healthcare utilization and OOP costs was
attributable to outpatient rather than inpatient service use,
and was not modified by relative wealth.
Our findings also show that when seeking healthcare,
individuals with probable depression most often sought
care from pharmacists, with very few consulting mental
health specialists for healthcare. Despite their more fre-
quent use, annual pharmacist costs were much lower
than for consultations with specialist doctors ($7.97
USD/year compared to $36.99 USD/year) and general
doctors ($12.04 USD/year).
Strengths and limitations
This is the only population-based study that we are
aware of from Nepal or any other low-income country to
simultaneously evaluate dose-dependent associations be-
tween depression and healthcare utilization and OOP
expenditure and to examine utilization of different ser-
vice providers. We also minimised the risk of misclassifi-
cation bias because we validated the PHQ-9 in this
setting and used the total PHQ-9 score as a continuous
variable for most statistical analyses.
However, our findings should be interpreted in light of
some limitations. Firstly, Due to the cross-sectional de-
sign, (and because the PHQ-9 refers to symptoms of
Table 2 Associations between PHQ-9 scores and annual healthcare utilization and OOP expenditure among adults in Chitwan
district, Nepal, 2013
Utilization (Number of visits) OOP Expenditure (US dollars)
IRR (95% CI) P value β (95% CI) P value
Inpatient Admissions N = 479 Univariate 1.08 (0.94–1.25) 0.280 3.63 (−0.99–8.26) 0.124
Multivariate 1.07 (0.94–1.22) 0.314 4.00 (−1.84–9.84) 0.179
Age 1.00 (0.94–1.22) 0.981 4.37 (−3.63–13.49) 0.284
Female 0.70 (0.32–1.54) 0.378 −83.84 (−211.31–43.62) 0.197
Relative wealth index 0.96 (0.71–1.30) 0.794 26.92 (−19.08–72.92) 0.251
Outpatient Consultations N = 479 Univariate 1.14 (1.06–1.23) < 0.0001 5.52 (2.36–8.67) 0.001
Multivariate 1.14 (1.06–1.23) < 0.0001 5.36 (2.26–8.47) 0.001
Age 1.00 (0.98–1.01) 0.549 0.62 (−0.22–1.45) 0.150
Female 1.07 (0.66–1.71) 0.786 17.26 (−7.58–42.09) 0.173
Relative wealth index 1.00 (0.66–1.71) 0.986 6.49 (0.18–13.11)) 0.044
Total Healthcare N = 479 Univariate 1.14 (1.07–1.22) < 0.0001 9.15 (3.12–15.18) 0.003
Multivariate 1.14 (1.07, 1.22) < 0.0001 9.37 (2.15–16.58) 0.011
Age 1.00 (0.98–1.01) 0.563 4.99 (−3.52–13.49) 0.251
Female 1.05 (0.67–1.65) 0.817 −66.59 (−204.87–71.70) 0.345
Relative wealth index 1.00 (0.88–1.13) 0.982 33.57 (−16.17–83.31) 0.186
Healthcare utilization and OOP Expenditure were estimated using negative binomial regression and bootstrapped linear regression to model incidence rate ratios
(IRR), and β coefficients respectively along with and 95% confidence intervals
Both IRR and β coefficients were adjusted by survey-sampling weights and multivariate analyses were further adjusted for sex, gender and relative wealth index
Estimates reflect changes associated with a one unit increase in PHQ-9 score after adjustment for age, gender and relative wealth index
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depression in the previous 2 weeks, whereas the CSRI re-
cords healthcare utilization and expenditure for the pre-
vious 3 to 12months), it is difficult to infer causality or
determine the true temporal relationship between de-
pression and healthcare utilization. However, depression
typically adopts a chronic relapsing and remitting course
and it is likely that these symptoms preceded the 2 week
recall period.” Secondly, in the absence of reliable health
service records, we measured utilization and expenditure
by self-report, which may be subject to recall bias, al-
though we restricted the recall period for outpatient
utilization to 3 months to minimise this. Conversely, by
extrapolating outpatient healthcare utilization from 3
months to 1 year, we may have introduced infrequency
bias due to seasonal fluctuations, which could have led
us to over or underestimate these associations. Thirdly,
we cannot rule out unmeasured confounding from
urban or rural residence, which are known to influence
healthcare access in Nepal [46, 47] or physical
comorbidities, as neither were recorded in this study.
However, only 13% of participants with depression who
used healthcare reported doing so for chronic health
problems and previous studies that have adjusted for co-
morbidities have still found residual associations [22].
Fourth, these findings may not be generalizable to other
regions in Nepal, although we used a large, population-
based sample, in which secondary level educational at-
tainment was fairly representative of national estimates,
suggesting that this was not an obvious source of selec-
tion bias [48]. Finally, this was a secondary data analysis
designed to explore healthcare utilization in people with
depression in Nepal and we could not therefore perform
sample size calculations a priori. We have also not per-
formed retrospective power calculations due to the na-
ture of the exposures and outcomes and the inaccuracies
associated with these types of calculations [49–51].
However, our results may still be subject to errors of ei-
ther sign (Type S) or magnitude (Type M), which we are
Fig. 1 Outpatient Provider-Specific Healthcare utilization by probable depression status among adults in Chitwan District, Nepal, 2013
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unable to account for [49]. Our findings are therefore
more exploratory than confirmatory and adequately
powered prospective studies are now necessary to con-
firm these associations and establish the direction of
causation and the underlying mechanisms.
Comparison with previous literature
The pattern of increased healthcare consumption by
people with probable depression in Nepal reported here is
consistent with observations from high-income countries,
where the greatest direct healthcare costs are also attribut-
able to general healthcare rather than specialist mental
healthcare utilization [12]. Our finding that excess ex-
penditure by people with depression was largely
accounted for by outpatient service use is consistent with
findings from India [21, 52], Brazil [53] and other middle-
income countries [22], which demonstrate 14 to 36% in-
creases in community healthcare utilization among people
with depression, and suggest that depression is a risk fac-
tor for catastrophic health expenditure [37]. This is the
first study that we know of to independently report
hospital admission frequency and OOP healthcare expen-
ditures in people with symptoms of depression in LMIC,
although a study from Canada also found no significant
increases in health service related costs of admissions [12].
Whether people with depression seek more help from
pharmacists in LMIC has not been studied before, but in
Brazil it has been reported that depressed individuals
use more medications than the general population [53].
It is important to note that the role of pharmacists in
Nepal is generally limited to the provision of over the
counter drugs rather than diagnoses or prescriptions. As
reported elsewhere in Nepal [46], we detected minimal
utilization of traditional healers for overall healthcare
needs. This may be due to increased stigmatization of
the use of traditional healers [54] and a general prefer-
ence for ‘pill-based’ treatments in South Asia [55]. Con-
versely, only 2% of people with depression who utilized
outpatient services were seen by a psychiatrist, which is
consistent with previous literature and the shortage of
mental health specialists in the area [32]. Our findings
are therefore more exploratory than confirmatory and
Fig. 2 Outpatient sector-specific mean OOP healthcare expenditures (US Dollars/yr) by probable depression status
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adequately powered prospective studies are now neces-
sary to confirm these associations and establish the direc-
tion of causation and the underlying mechanisms.
Mechanisms and implications
Given the limitations of the data described above, there
are multiple potential explanations of the association be-
tween depression symptoms and healthcare utilization
and expenditure, which are not necessarily mutually ex-
clusive: (1) The first explanation is that depression leads
to increased utilization of services through somatization
– that is, the manifestation of psychological distress as
physical symptoms – which has been demonstrated pre-
viously [56] (Fig. 3a). (2) Alternatively, depression may
lead to increased healthcare utilization because of its as-
sociation with physical comorbidities, which are both a
risk factor for and a consequence of depression [57–59]
(Fig. 3b). (3) Finally, OOP healthcare expenditure can re-
sult in poverty [38], which in turn is a major risk factor
for depression [16], raising the possibility that the causal
pathway acts in the opposite direction (Fig. 3c).
There is evidence to support the plausibility of each of
these pathways. In support of the first and second hypoth-
eses, which posit a causal role of depression, associations
have been shown prospectively between depression and
health service utilization in Canada [12] and the United
States [60]. Further, somatization is a common presenta-
tion of depression in South Asia [61–65] and particularly
in Nepal [66], which could explain the increased demand
for physical rather than mental healthcare [56] and might
possibly be consistent with the 20% or so who sought care
for gastrointestinal symptoms or joint pains (although
somatization is a diagnosis of exclusion and we cannot as-
sume that these are not indicative of real underlying path-
ology). Previous analyses have also shown that only 8.1%
of people with probable depression in this sample re-
ported actively seeking treatment specifically for depres-
sion symptoms [67], which is far lower than the 71% who
sought any healthcare at all. This may relate to the lack of
effective detection and treatment of depression in primary
care [68, 69], and possibly to low perceived need for inter-
vention for psychological symptoms [70].
Fig. 3 Schematic Representation of Potential Causal Pathways Between Depression and Healthcare Utilization and OOP Expenditure
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At the same time, a growing evidence base also dem-
onstrates that depression increases the risk of a variety
of physical health problems [71–74], which could medi-
ate the relationship between depression and healthcare
utilization. Cross-sectional evidence from Nepal sup-
ports an association between depression and chronic co-
morbidities [75, 76]. Nonetheless, studies that have
controlled for these comorbidities have still found a re-
sidual association between depression and increased
healthcare utilization, suggesting that depression also ex-
erts an independent effect on treatment-seeking [22].
Recent evidence shows that primary care workers can be
trained [24] to improve detection of depression and deliver
mhGAP-based interventions [26] (including psychoeduca-
tion and medication) to effectively treat depression and re-
duce disability in Nepal [25]. If depression is the primary
driver of increased healthcare utilization among this group
(either directly, by somatization, or indirectly, by impacting
on general health) then we would expect the roll-out of
such services to reduce excess healthcare use and associ-
ated OOP expenditure. Elsewhere, the integration of men-
tal health services into primary care in Andhra Pradesh in
India [39] has been shown to substantially reduce OOP
healthcare expenditures. In Nepal, the estimated combined
costs of scaling-up services for psychosis, depression and
epilepsy are less than $1.30 USD/capita/year [27]. In con-
trast to the additional $9 USD/year OOP incurred by
people in this study for each increment in PHQ-9 score,
this is a relatively small investment, which might minimise
financial impoverishment, whilst reducing symptoms of de-
pression and hopefully break the link between the two.
However, the notion that OOP healthcare expenditures
lead to depression (Fig. 3c) also finds some empirical sup-
port. Healthcare expenditure represents an exceptionally
large share of total household expenditure in Nepal [15]
and therefore poses a risk of catastrophic expenditure, im-
poverishment and widened inequalities [15], which are
significant determinants of depression [16]. In support of
this, we found that the poorest individuals were most
likely to suffer from depression but did not appear to
forego care, which we would expect to cause further im-
poverishment. We also observed that people with depres-
sion commonly presented with signs and symptoms of
infection, which we also expect to be more common in
areas of deprivation. Thus, the lack of financial protection
for people with depression is likely to reinforce a vicious
cycle of further healthcare utilization and greater impover-
ishment. According to this model, introducing financial
protections would reduce depression prevalence. Support-
ing the uptake of social health insurance schemes in Nepal
could therefore break the cycle between the impoverishing
effects of healthcare utilization and the associated risks of
depression. In support of this hypothesis, studies from the
United States show that introduction of Medicaid led to
9% reductions in depression prevalence and near elimin-
ation of catastrophic expenditure [77].
Given previous evidence of the inter-relationships be-
tween poverty and financial shocks, depression, and
physical health, it seems probable that the observed as-
sociation between depression and healthcare utilization
and expenditure results from a combination of these
pathways Fig. 3d). Indeed, the idea that physical health,
mental health and poverty interact synergistically
through multiple complex pathways underlies syndemics
theory [78–80]. Further research would be necessary to
empirically confirm the relative contribution of each of
these mechanisms in the Nepali context, but a combin-
ation of increased financial protection for healthcare and
the provision of effective depression treatment might
reasonably be recommended to break this cycle.
In terms of how to provide depression treatment as part
of UHC, the low frequency of hospital admissions support
proposals to integrate mental health services into primary
rather than secondary care in LMIC. The low cost and fre-
quent consultation of pharmacists, relative to general and
specialist doctors, is also relevant to policy as it indicates
an additional cadre of healthcare providers who are in fre-
quent contact with the target population. Evidence from
PRIME demonstrates that task-sharing by training and
supervising non-specialist health workers can improve de-
pression detection rates [69] and mhGAP-based interven-
tions for depression in Nepal have been found to be most
effective when they were supplemented with psychosocial
treatments delivered in the community [24]. Our findings
suggest that enlisting pharmacists to identify potential de-
pression patients and refer them to community counsel-
lors to receive appropriate treatments such as the Healthy
Activity Program [81], might be a fruitful strategy to both
reduce the provision of unnecessary medications (and
therefore OOP costs) and ultimately provide both mental
and physical health benefits [25].
Unanswered questions and future research
This study contributes to the evidence base on health-
care utilization and expenditure by demonstrating that,
in Nepal, adults with probable depression use a dispro-
portionate amount of healthcare and incur increased
healthcare expenditures. Future studies should also in-
vestigate whether providing mhGAP-based interventions
for depression mitigates excess utilization of health ser-
vices by people with depression, to inform their inclu-
sion in social health insurance packages of care and to
prevent impoverishment in this group. Modelling studies
have estimated that strengthening primary health care in
LMIC to diagnose and treat depression could result in
productivity gains as high as $4 USD for every $1 USD
invested [82] and the real-world effect of such an ap-
proach should therefore be evaluated. Equally, the
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impact of expanding financial protection for depression
as part of UHC should also be evaluated in LMIC. Fi-
nally, the feasibility of training pharmacists in Nepal to
recognise depression and signpost individuals with de-
pression to appropriate care should be investigated.
Conclusion
Our findings show that people with symptoms of de-
pression in central Nepal utilise more healthcare and
incur greater OOP costs compared to people without
depression. This economic burden is accounted for by
frequent visits to pharmacists and costly visits to general
and specialist doctors, with minimal use of specialist
mental health care. These findings reinforce the emer-
ging consensus that policy-makers in low-income coun-
tries must improve universal access to cost-effective
treatments for depression through integration of mental
healthcare services into primary healthcare, as well as
expanding financial protection as part of universal health
coverage initiatives, to reduce the financial burden of de-
pression on patients. Engaging pharmacists and primary
care doctors as key stakeholders may help to improve
case detection and access to appropriate evidence-based
services, which can be delivered in the community. Fu-
ture research should investigate the impact of financial
protection on depression, and of depression treatment
on healthcare utilization and expenditure.
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